ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
1-Year Return
45.88%
This Quarter Return
+6.92%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$108M
AUM Growth
+$6.52M
(+6.4%)
Cap. Flow
+$1.42M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
50.36%
Holding
47
New
11
Increased
13
Reduced
10
Closed
12
Top Buys
| 1 |
DaVita
DVA
|
$5.26M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$4.39M |
| 3 |
Incyte
INCY
|
$3.41M |
| 4 |
Insmed
INSM
|
$3.26M |
| 5 |
Pfizer
PFE
|
$3.01M |
Top Sells
| 1 |
OPTN
OptiNose
OPTN
|
$9.4M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$7.82M |
| 3 |
Exact Sciences
EXAS
|
$5.08M |
| 4 |
Quest Diagnostics
DGX
|
$2.7M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$2.18M |
Sector Composition
| 1 | Healthcare | 86.09% |
| 2 | Technology | 0% |
